Topics
Glioblastoma | Treatment | Radiotherapy | Re-irradiation
Home > Publications > Topics > Glioblastoma > Treatment > Radiotherapy > Re-irradiation
Chen ATC, Serante AR, Ayres AS,
Tonaki JO, Moreno RA, Shih H, Gattás GS, Lopez OVM, Reis
Dos Santos de Jesus G, de Carvalho IT, Marotta RC, Marta GN, Feher
O, Neto HS, Ribeiro ISN, da Conceição Vasconcelos
KGM, Figueiredo EG, Weltman E.
Prospective
Randomized Phase 2 Trial of Hypofractionated Stereotactic
Radiotherapy of 25 Gy in 5 fractions compared to 35 Gy in 5
fractions in the Reirradiation of Recurrent Glioblastoma.
Int
J Radiat Oncol Biol Phys.
2024 Jan 15:S0360-3016(24)00026-9. doi:
10.1016/j.ijrobp.2024.01.013. PMID:
38232937. Interventional
study˰
ˍ
Shields LB, O'Dell P, Daniels MW, Sevak PR, Highfield HA,
Sinicrope KD, Sun DA, Spalding AC.
Impact
of Reirradiation Utilizing Fractionated Stereotactic Radiotherapy
for Recurrent Glioblastoma.
Cureus.
2024 Jan 26;16(1):e53001. doi:
10.7759/cureus.53001. PMID:
38406061. Observational study. ˍ
*Straube C, Combs SE, Bernhardt D, Gempt J, Meyer B, Zimmer C,
Schmidt-Graf F, Vajkoczy P, Grün A, Ehret F, Zips D, Kaul
D.
Adjuvant re-irradiation vs. no early
re-irradiation of resected recurrent glioblastoma: pooled
comparative cohort analysis from two tertiary centers.
J
Neurooncol. 2024 Mar 23. doi:
10.1007/s11060-024-04633-2. PMID:
38520571. Observational study.
ˍ
Cuccia F, Jafari F, D'Alessandro S, Carruba G, Craparo G, Tringali
G, Blasi L, Ferrera G.
Preferred
Imaging for Target Volume Delineation for Radiotherapy of
Recurrent Glioblastoma: A Literature Review of the Available
Evidence.
J
Pers Med. 2024 May 17;14(5):538. doi:
10.3390/jpm14050538. PMID:
38793120. Review. ˍ
Reinders AN, Koshy M, Korpics M.
The
Patterns of Failure and Prognostic Impact of Tumor Location in
Patients Undergoing Reirradiation for Glioblastoma.
Cureus.
2024 Sep 6;16(9):e68820. doi:
10.7759/cureus.68820. PMID:
39371788. Observational study. ˍ
Lucas Calduch A, Macià Garau M, Villà Freixa S,
García Expósito N, Modolell Farré I, Majós
Torró C, Pons Escoda A, Mesía Barroso C, Vilariño
Quintela N, Rosselló Gómez A, Plans Ahicart G,
Martínez García M, Esteve Gómez A, Bruna
Escuer J.
Salvage reirradiation for
recurrent glioblastoma: a retrospective case series analysis.
Clin
Transl Oncol. 2024 Oct 10. doi:
10.1007/s12094-024-03750-8. PMID:
39388047. Observational study˰
ˍ
Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA,
Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A,
Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL,
Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang
K, Wucherpfennig KW, Wen PY, Reardon DA.
Re-irradiation
plus pembrolizumab: Phase II study for recurrent glioblastoma
patients.
Clin
Cancer Res. 2024 Nov 8. doi:
10.1158/1078-0432.CCR-24-1629. PMID:
39513953. Interventional study˰
ˍ
*Rahman R, Preusser M, Tsien C, Le Rhun E, Sulman EP, Wen PY,
Minniti G, Weller M.
Point/Counterpoint:
The role of reirradiation in recurrent glioblastoma.
Neuro
Oncol. 2024 Nov 11:noae209. doi:
10.1093/neuonc/noae209. PMID:
39527460. Perspective. ˍ
Rogers S, Gross M, Ermis E, Cosgun G, Baumert BG, Mader T,
Schroeder C, Lomax N, Alonso S, Ademaj A, Lazeroms T, Lee SY,
Mayinger M, Mamot C, Schwyzer L, Schubert GA, Riesterer O.
Re-irradiation for recurrent
glioblastoma: a pattern of
care analysis.
BMC Neurol. 2024 Nov 26;24(1):462.
doi:
10.1186/s12883-024-03954-z. PMID:
39587462. Observational study. ˍ